• Profile
Close

The effect of lithium on the progression free and overall survival in patients with metastatic differentiated thyroid cancer undergoing radioactive iodine therapy

Clinical Endocrinology Jul 13, 2018

Luo H, et al. - A cohort study was performed to compare the effectiveness of three methods of preparation for radioactive iodine (RAI) therapy in metastatic differentiated thyroid cancer (DTC): thyroid hormone withdrawal (THW), THW with pre-treatment with lithium (Li) (THW+Li), and recombinant human TSH (rhTSH). Findings revealed that the older age was correlated with shorter overall survival (OS). On the other hand, disease burden affects OS and progression-free survival (PFS) in these patients. However, longer PFS was linked to the presence of distant metastases limited to the lungs only. It was noted that the method of preparation for RAI therapy did not affect the outcome.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay